TITLE

BENEFICIAL EFFECTS OF PREBIOTICS, GERMINATED BARLEY FOODSTUFF IN THE LONG TERM TREATMENT OF ULCERATIVE COLITIS: A MULTICENTRE OPEN CONTROL STUDY

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA96
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article studies beneficial effects of prebiotics, germinated barley foodstuff (GBF) in the long term treatment of ulcerative colitis (UC) through multicenter open control study. GBF is a prebiotic foodstuff that effectively increases luminal butyrate production by stimulating the growth of protective bacteria. The study revealed that oral GBF treatment may have the potential to prolong the remission period, in addition to decreasing clinical activity index during the active period. These results support the use of GBF administration as a new adjunctive UC treatment.
ACCESSION #
13219189

 

Related Articles

  • The Use of Laparoscopic Techniques in Surgery for Mucosal Ulcerative Colitis. Sonoda, Toyooki // Seminars in Laparoscopic Surgery;Dec2003, Vol. 10 Issue 4, p169 

    The use of laparoscopic techniques when surgical therapy is required for the treatment of mucosal ulcerative colitis has been slow to develop; the surgery is extensive, and the instruments are limited. The often urgent nature of the surgery, along with the fragile inflamed colon, have...

  • A Prospective Randomized Observer-Blind 2-Year Trial of Azathioprine MonotherapyversusAzathioprine and Olsalazine for the Maintenance of Remission of Steroid-Dependent Ulcerative Colitis. Mantzaris, Gerassimos J.; Sfakianakis, Michael; Archavlis, Emmanuel; Petraki, Kalliopi; Christidou, Angeliki; Karagiannidis, Alexandros; Triadaphyllou, George // American Journal of Gastroenterology;Jun2004, Vol. 99 Issue 6, p1122 

    OBJECTIVE: The aim of this prospective study was to assess whether the coadministration of azathioprine (AZA) and olsalazine is superior to AZA monotherapy in maintaining remission of steroid-dependent ulcerative colitis (UC).METHODS: Patients with steroid-dependent UC in remission were...

  • MANAGEMENT OF SPASTIC, IRRITABLE COLON, WITH A NOTE ON ULCERATIVE COLITIS. Rosenblum, Louis A. // American Journal of Gastroenterology;Apr1958, Vol. 29 Issue 4, p407 

    Studies the management of spastic, irritable colon with emphasis on ulcerative colitis. Material and methods; Use of a preparation containing scopolamine methyl bromide, guar gum and a fecal softener; Interpretation of the findings.

  • Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis. Sandborn, William J.; Ghosh, Subrata; Panes, Julian; Vranic, Ivana; Su, Chinyu; Rousell, Samantha; Niezychowski, Wojciech // New England Journal of Medicine;8/16/2012, Vol. 367 Issue 7, p616 

    Background: Ulcerative colitis is a chronic inflammatory disease of the colon for which current treatments are not universally effective. One additional treatment may be tofacitinib (CP-690,550), an oral inhibitor of Janus kinases 1, 2, and 3 with in vitro functional specificity for kinases 1...

  • Balsalazide: increasing the choice for patients with ulcerative colitis.  // Drugs & Therapy Perspectives;Oct2003, Vol. 19 Issue 10, p1 

    Balsalazide (Colazide®, Colazol®) is a recent addition to the aminosalicylate drugs used to treat ulcerative colitis. After cleavage by bacterial azo-reductases in the colon, the active moiety mesalazine (mesalamine or 5-aminosalicylic acid) and an inert carrier compound are released. Oral...

  • High-Dose Cyclosporine Had No Additional Clinical Benefit over Low-Dose Cyclosporine for Severe Ulcerative Colitis. Van Assche, G.; D'haens, G.; Noman, M. // Annals of Internal Medicine;9/7/2004, Vol. 141 Issue 5, p377 

    This article presents information on benefits of high-dose cyclosporine, over low-dose cyclosporine for the treatment of ulcerative colitis. Cyclosporine is known to be highly effective for patients with severe ulcerative colitis, inducing remission in 50% of patients treated acutely. However,...

  • THE USE OF CORTICOTROPIN-ZINC HYDROXIDE IN THE TREATMENT OF ULCERATIVE COLITIS AND OTHER COLONIC DISORDERS. Riese, Jacob A. // American Journal of Gastroenterology;Oct1957, Vol. 28 Issue 4, p452 

    1. The specific etiology of ulcerative colitis remains unknown. Infection and emotion remain prime etiologic theories. 2. The disease is reviewed with regard to pathology, symptomatology, and differential diagnosis. 3. Treatment of ulcerative colitis and other functional colonic disorders with...

  • EXPRESSION OF LECTINS IN NONSPECIFIC ULCERATIVE COLITIS. Markova, A. A.; Kashkina, E. I.; Maslyakova, G. N. // Saratov Journal of Medical Scientific Research / Saratovskii Nau;Oct-Dec2012, Vol. 8 Issue 4, p937 

    Purpose: To analyze the expression of lectins in mucosa of a colon in patients with ulcerative colitis (UC), depending on the duration, severity, location and activity of the inflammatory process. Materials and methods: A total of 48 patients with ulcerative colitis and 15 healthy people have...

  • Topical Rosiglitazone Treatment Improves Ulcerative Colitis by Restoring Peroxisome Proliferator-Activated Receptor-γ Activity. Pedersen, Gitte; Brynskov, Jørn // American Journal of Gastroenterology;Jul2010, Vol. 105 Issue 7, p1595 

    OBJECTIVES:Impaired epithelial expression of peroxisome proliferator-activated receptor-γ (PPARγ) has been described in animal colitis models and briefly in patients with ulcerative colitis, but the functional significance in humans is not well defined. We examined PPARγ expression and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics